Image Gettyimages 161140672

Leading Hidradenitis Suppurativa Treatments in the Market

Spread the love

Spread the loveLeading Hidradenitis Suppurativa Treatments in the Market Currently, some of the top medications for treating hidradenitis suppurativa (HS) include BIMZELX (bimekizumab) by UCB Biopharma, COSENTYX (secukinumab) by Novartis, and HUMIRA (adalimumab) by AbbVie/Eisai. Until 2023, HUMIRA dominated the market, even though its US patent expired in December 2016. AbbVie’s strong patent defense in…

Read More
1724126432478 (002)

Exploring Pharmacokinetic (PK) Data and Strategies for Analysis

Spread the love

Spread the loveSome basics of Pharmacokinetics (PK) analysis: Pharmacokinetics refers to the study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. The pharmacokinetic analysis set is created to analyze PK data collected from study participants. This set typically includes patients who have received the drug of interest and have available PK…

Read More
Fb Img 1726459477548

From ‘After’ to ‘Before’: Smita Bhatnagar’s Evolution Through TC21

Spread the love

Spread the loveFrom ‘After’ to ‘Before’: Smita Bhatnagar’s Evolution Through TC21 In April 2024, I, Smita Bhatnagar, celebrated a significant milestone in my fitness journey by sharing my ‘before’ and ‘after’ photos. What was once a remarkable transformation is now my new ‘before,’ thanks to my incredible journey with the TC21 Transformation Challenge. This experience…

Read More
Fb Img 1726455384963

Gut Reset? Gut Detox? Gut Cleanse? – What You Need to Know!

Spread the love

Spread the loveGut Reset? Gut Detox? Gut Cleanse? – What You Need to Know! Author: Prachi Gupta, Coach, Fittr In today’s world, terms like gut reset, gut detox, and gut cleanse have become buzzwords, frequently popping up on social media. But before you jump on the latest trends, let’s clarify a few essential facts! 🦠…

Read More
Images (13)

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer

Spread the love

Spread the loveBristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer Bristol Myers Squibb (BMS) is set to push its PD-1/LAG-3 combination therapy, Opdualag, into phase 3 trials for first-line non-small cell lung cancer (NSCLC), two years after its initial FDA approval in melanoma. The registrational trial, named RELATIVITY1093, will…

Read More
Images (9)

Keytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care

Spread the love

Spread the loveKeytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care Merck’s Keytruda (pembrolizumab) has achieved a significant milestone in the fight against early-stage triple-negative breast cancer (TNBC), with new data demonstrating a substantial improvement in overall survival rates. This development follows an earlier controversy over its approval based on preliminary endpoints….

Read More